Cravath’s New York Office Moves to Two Manhattan West
On September 20, 2022, Cravath partner John W. White participated in “Navigating the Next Phase of ESG Reporting,” a webcast hosted by EY as part of its “Think ESG” webcast series. John’s session provided an overview of environmental, social and governance disclosures and the proposed regulatory changes, and reviewed the key potential regulation impacts on financial statement preparers and investors.
Deals & Cases
November 29, 2021
Cravath represented Vaxxinity, Inc. in connection with its initial public offering. Vaxxinity is a U.S.‑based global biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Shares began trading on November 11, 2021 on The Nasdaq Global Market.
Deals & Cases
July 29, 2021
Cravath represented Robinhood in connection with its initial public offering. Robinhood raised approximately $1.9 billion of net proceeds in the IPO. Shares began trading on July 29, 2021 on the NASDAQ exchange.
Deals & Cases
November 17, 2020
On November 17, 2020, Deutsche Börse AG, Institutional Shareholder Services Inc. (“ISS”) and Genstar Capital LLC announced that Deutsche Börse will acquire approximately 80% of leading governance, ESG data and analytics provider ISS, valuing ISS at $2.275 billion for 100% of the business. Genstar Capital and current management will continue to hold a stake of approximately 20%. Cravath, alongside Hengeler Mueller, is representing Deutsche Börse in connection with the transaction.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.